Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Twilla, Jennifer D; Algrim, Amie; Adams, Ethan H; Samarin, Michael; Cummings, Carolyn; Finch, Christopher K

Twilla, Jennifer D; Algrim, Amie; Adams, Ethan H; Samarin, Michael; Cummings, Carolyn; Finch, Christopher K.

Affiliation

Twilla JD; Methodist University Hospital, Memphis, Tennessee; College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
Algrim A; Methodist University Hospital, Memphis, Tennessee.
Adams EH; College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
Samarin M; Methodist University Hospital, Memphis, Tennessee; College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
Cummings C; Methodist University Hospital, Memphis, Tennessee; College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
Finch CK; College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee. Electronic address: cfinch@uthsc.edu.

Am J Med Sci ; 360(1): 35-41, 2020 07.

Article in En | MEDLINE | ID: mdl-32376001

Subject(s)
Key words

Bacteremia; Cefazolin; MSSA; Nafcillin; Treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Staphylococcus aureus / Cefazolin / Bacteremia / Anti-Bacterial Agents / Nafcillin Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Am J Med Sci Year: 2020 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google